REPL · Replimune Group, Inc. · Earnings Call Transcripts & Audio
$12.92
-0.32 (-2.42%)
At close · Sep 11
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“As described in the Company's Annual Report on Form 10-K for the year ended March 31, 2026, substantial doubt existed about the Company's ability to continue as a going concern. The conditions that raised substantial doubt have been subsequently alleviated, as the Company raised approximately $141.0 million in net proceeds from an equity offering in August 2026.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.22B
Shares
94.22M
Replimune Group, Inc. Earnings Call Transcripts
Quarterly earnings calls for Replimune Group, Inc. (REPL), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Earnings call
FY27 · Q1
2026-08-14
Replimune Group, Inc. (REPL) Q1 2027 Earnings Call
Diluted EPS
$-0.72
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-05-22
Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript
Confident tone
RP1 regulatory progress and PDUFA
Anti-PD-1 failed melanoma market opportunity
RP1 commercial launch preparation
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2023-11-07
Replimune Group, Inc. (REPL) Q2 2024 Earnings Call
Diluted EPS
$-0.90
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-01-15
Replimune Group, Inc. (REPL) Q3 2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–4 of 4 earnings calls
Key facts
CIK
1737953
CUSIP
76029N106
13F (30d)
73 filings
73 filers
Visit website
Investor relations